Contents & References of A comparative study of the quality of life before and after therapeutic interventions in patients with acute coronary syndrome
List:
Chapter One: Statement of the Problem
1-1 Introduction.. 2
1-2 Goals and Assumptions.. 4
1-2-1 General Goal.. 4
1-2-2 Specific Goals.. 4
1-2-3 Hypothesis.. 5
1-3 Definition of Key Words. 5
1-3-1 quality of life.. 5
1-3-1-1 theoretical definition.. 5
1-3-1-2 operational definition.. 5
1-3-2 therapeutic interventions.. 5
1-3-2-1 operational definition: includes PTCA, CABG and drug interventions. 5
1-3-3 aggressive and non-aggressive groups. 5 1-3-3-1 operational definition. 6
Chapter Two: conceptual framework and research background
2-1 acute coronary syndrome. 9
2-2-2-1 Unstable angina.. 9
2-2-2-2 Myocardial infarction without ascending NSTEMI) 10
2-2-3 cardiac angina or acute coronary syndrome. 10
2-3 Definition of cardiac angina.. 10
2-3-1 Stable angina.. 10
2-3-2 Unstable angina.. 11
2-3-2-1 Examining the causes of unstable angina or infarction. 11
2-3-2-1-1 stages of atherosclerosis. 12
2-3-2-1-1-1 cholesterol and lipoprotein. 12
2-3-2-1-1-2 oxidation. 12
2-3-2-1-1-3 inflammatory response. 12
2-3-2-1-1-3-1 vessel closure. 13
2-4 clinical symptoms of coronary syndrome. 13
4-2-1 Quality of pain .. 14
4-2-2 Duration of pain .. 14
4-2-3 Location of pain .. 14
4-2-4 Pain starters. 14
4-2-5 heart attack, the latest case of acute coronary syndrome. 15
2-5 manifestations of coronary syndrome disease. 15
2-5-1 Prinzmetal's angina.. 15
2-5-2 silent ischemia.. 15
2-5-3 X syndrome.. 16
2-6 methods of diagnosing acute coronary syndrome or heart attack. 16
2-6-1 History and clinical examination. 16
2-6-2 heart tape or ECG .. 17
2-6-3 laboratory markers. 17
2-6-4 Non-invasive tests. 18
2-6-4-1 Echocardiography. 18
2-6-4-2 Exercise test.. 18
2-6-4-3 Thallium scan.. 18
2-6-4-4 Angiography.. 19
2-6-4-5CT Angiography. 19
2-5 ways of treatment.. 20
2-5-1 drug treatment.. 20
2-5-1-1 nitroglycerin or nitrates. 20
2-5-1-2 betablocker.. 21
2-5-1-3 verapamil - heparin and LMWH. 21
2-5-1-4 unstable angina.. 23
2-5-1-5 myocardial infarction with ST segment elevation. 23
Coronary interventions through the skin. 23
2-5-2 stent.. 23
2-5-3 coronary artery bypass surgery. 25
2-5-3-1 importance.. 25
2-5-4 cardiopulmonary bypass. 25
2-5-4-1 risks.. 26
2-5-5 risk factors of coronary syndrome. 26
2-5-5-1 age .. 27
2-5-5-2 gender.. 27
2-5-5-3 genetic factors. 27
2-5-5-4 race.. 27
2-5-5-5 quality of life.. 28
2-5-5-1 history of quality of life. 30
2-5-5-2 The concept of quality of life from the point of view of theorists. 31
2-5-5-2-1 Kalman.. 31
2-5-5-2-2 Goodman.. 32
2-5-5-2-3 Reiff and Singer. 32
2-5-5-2-4 Murray.. 32
2-5-5-2-5 David Phillips. 33
2-5-5-3 characteristics of quality of life. 33
2-5-5-3-1 multi-dimensionality. 33
2-5-5-3-2 being subjective.. 34
2-5-5-3-3 being dynamic.. 34
2-5-5-4 social psychological and sociological approach to the concept of quality of life. 34
2-5-5-4-1 social learning theory. 35
2-5-5-4-2 Durkheim's theory of anomie. 35
2-5-5-4-3 Parsons theory of social action. 36
2-5-5-4-4 Simmel's theory.. 37
2-6 background of research.. 39
2-6-1 external research.. 39
2-6-2 internal research.. 41
Chapter 3: research methodology
3-1 type of research.. 44
3-2 Research environment.. 44
3-3 Research community.. 44
3-4 study entry and exit criteria. 44
3-4-1 entry criteria.. 44
3-4-2 exclusion criteria. 45
3-5 Sampling method.. 45
3-6 Determining the sample size.. 45
3-7 Implementation method46
3-8 information gathering methods. 47
3-9 data collection tools. 47
3-10 SF6 scoring questionnaire. 47
3-11 Introduction of research variables. 50
3-12 information analysis method. 51
3-13 used software. 51
3-14 Ethical considerations. 51
Chapter 4: description and analysis of data (findings)
4-1 General findings of the research. 53
4-2- Studying the demographic characteristics of patients with acute coronary syndrome. 54
4-3 Determining the quality of life of patients with acute coronary syndrome at the beginning of the study. 56
4-4- Determining the quality of life of patients with coronary syndrome two months after treatment 58
5-4 Comparing the quality of life of patients before and after therapeutic interventions 63
Chapter five: discussion and conclusion
5-1 Discussion and conclusion. 66
5-2 Conclusion. 69
3-5 suggestions. 69
5-3-1 Practical suggestions. 69
5-3-2 Research proposals. 70
Sources and sources. 72
Appendix. 79
English abstract. 85
Source:
1. Zhenxiang Z, Melissa W. Economic burden of illness of acute coronary syndromes: medical and productivity costs. BMC Health Services Research 2011;11-35.
2. Celi?ski R, Fizjoterapii I. The influence of undertaken invasive or medical treatment on the quality of life of patients with acute coronary syndrome. Organ Polskiego Towarzystwa Lekarskiego 2008;25(148):320-5.
3. Ali Ghaleiha A, Emami F, Naghsh Tabrizi B, Ali Hassani A.A Survey on the Frequency of Depression and Anxiety in the Patients with Acute Coronary Syndrome. Sci J Hamadan Univ Med Sci 2011;17(4): 43-49.
4. Finegold JA, Asaria P, Francis DP. Mortality from ischemic heart disease by country, region, and age: Statistics from World Health Organization and United Nations. International journal of cardiology 2012:78-98.
5. Giugliano RP, Braunwald E. The Year in Non ST-Segment Elevation Acute Coronary Syndrome. Journal of the American College of Cardiology 2011;58(22):2342-54.
6. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart Disease and Stroke Statistics 2011 Update. Circulation 2012;123(4):18-209.
7. Hamshahrionline. Cardiac death in Iran is higher than global statistics 2011. Available at www.hamshahrionline.ir.
8. Montazerghaem h, Asar o, Safaei n. Assessing patient's quality of life after open heart surgery in Bandar Abbas, Iran. Medical journal of Hormozgan University 2012:24-45.
9. Wieser S, Rüthemann I, De Boni S, Eichler K, Pletscher M, Radovanovic D, et al. Cost of acute coronary syndrome in Switzerland in 2008. Swiss medical weekly 2008;142-158.
10. Miri r, Asadzadeh R, Mirzaie V. Surveying primary ECG findings in emergency unit and prognosis of acute coronary syndrome. Paghohande journal 1388.14(4):215-218.
11. Arnold SV, Morrow DA, Lei Y, Cohen DJ, Mahoney EM, Braunwald E, et al. Economic Impact of Angina After an Acute Coronary Syndrome Insights From the MERLIN-TIMI 36 Trial. Circulation: Cardiovascular Quality and Outcomes 2009;2(4):344-353.
12. Tung HH, Chen CY, Lin KC, Chou NK, Lee JY, Clinciu DL, et al. Classification and regression tree analysis in acute coronary syndrome patients. World Journal of Cardiovascular Diseases 2012; 2: 177-183.
13. Spertus JA, Dewhurst T, Dougherty CM, Nichol P. Testing the effectiveness of converting patients to long-acting antianginal medications: The Quality of Life in Angina Research Trial (QUART). American Heart Journal 2001;141(4):8-550.
14. Morgan MW, Deber RB, Llewellyn Thomas HA, Gladstone P, Cusimano R, O'rourke K, et al. Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. Journal of general internal medicine 2000;15(10):685-93.
15. Blankenship JC, Marshall JJ, Pinto DS, Lange RA, Bates ER, Holper EM, et al.